buthionine sulfoximine has been researched along with cystamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djurhuus, R; Mansoor, MA; Svardal, AM; Ueland, PM | 1 |
Chang, CC; Chang, LS | 1 |
Hussein, AS; Walter, RD | 1 |
Bolognia, JL; Osber, MP; Pawelek, JM; Sodi, SA | 1 |
Fraser, JA; McLellan, LI; Saunders, RD | 1 |
Cahoon, RE; Chen, S; Jez, JM | 1 |
Barber, DS; Buzescu, R; Chopra, R; Ferrante, RJ; Fox, JH; Hersch, SM; Kazantsev, A; Norflus, F; Singh, B; Swindell, MK; Zucker, B | 1 |
Brimacombe, KR; Dulcey, AE; Goldsborough, AS; Gottesman, MM; Griffiths, G; Hall, MD; Handley, MD; Kannan, P; Pluchino, KM | 1 |
8 other study(ies) available for buthionine sulfoximine and cystamine
Article | Year |
---|---|
Modulation of glutathione content and the effect on methionine auxotrophy and cellular distribution of homocysteine and cysteine in mouse cell lines.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Cell Division; Cell Line; Culture Media; Cystamine; Cysteamine; Cysteine; Fibroblasts; Glutathione; Homocysteine; Intracellular Fluid; Leukemia, Experimental; Methionine; Methionine Sulfoximine; Mice | 1991 |
Biochemical regulation of the activity of gamma-glutamylcysteine synthetase from rat liver and kidney by glutathione.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Cystamine; Electrophoresis, Polyacrylamide Gel; Glutamate-Cysteine Ligase; Glutathione; Kidney; Kinetics; Liver; Methionine Sulfoximine; Molecular Weight; Organ Specificity; Rats | 1994 |
Purification and characterization of gamma-glutamylcysteine synthetase from Ascaris suum.
Topics: Animals; Ascaris suum; Buthionine Sulfoximine; Chromatography, Gel; Cystamine; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Helminth Proteins; Kidney; Kinetics; Methionine Sulfoximine; Molecular Weight; Rats; Species Specificity; Substrate Specificity | 1995 |
Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine.
Topics: Animals; Buthionine Sulfoximine; Cystamine; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Guinea Pigs; Hair Color; Hydroquinones; Melanoma; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Skin Pigmentation; Tumor Cells, Cultured | 1995 |
Drosophila melanogaster glutamate-cysteine ligase activity is regulated by a modifier subunit with a mechanism of action similar to that of the mammalian form.
Topics: Amino Acid Sequence; Animals; Antioxidants; Buthionine Sulfoximine; Cells, Cultured; Chromatography, Gel; Culture Media, Serum-Free; Cystamine; Drosophila melanogaster; Drosophila Proteins; Enzyme Inhibitors; Expressed Sequence Tags; Glutamate-Cysteine Ligase; Glutathione; Humans; Hydroquinones; Molecular Sequence Data; Protein Subunits; Recombinant Proteins; Sequence Alignment | 2002 |
Arabidopsis thaliana glutamate-cysteine ligase: functional properties, kinetic mechanism, and regulation of activity.
Topics: Adenosine Triphosphate; Arabidopsis; Binding Sites; Buthionine Sulfoximine; Chromatography, Gel; Cystamine; Cysteine; Dipeptides; Enzyme Inhibitors; Escherichia coli; Feedback, Physiological; Gene Expression; Glutamate-Cysteine Ligase; Glutamic Acid; Glutathione; Kinetics; Oxidation-Reduction; Oxidative Stress; Protein Conformation; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization | 2004 |
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Topics: Animals; Antioxidants; Brain; Buthionine Sulfoximine; Cystamine; Cysteine; Cytoprotection; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Gene Expression Regulation; Glutathione; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptides; Rats | 2004 |
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Orphan Drug Production; Paclitaxel; RNA Stability; RNA, Messenger; Structure-Activity Relationship; Tiopronin | 2011 |